We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+6.31%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
AUM
$542M
AUM Growth
+$101M
Cap. Flow
+$77.5M
Cap. Flow %
14.29%
Top 10 Hldgs %
47.74%
Holding
98
New
38
Increased
20
Reduced
13
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 39.77%
2 Communication Services 15.87%
3 Energy 6.16%
4 Financials 5.94%
5 Technology 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICPT
51
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$861K 0.16%
+2,612
New +$881K
PRTA icon
52
Prothena Corp
PRTA
$459M
$815K 0.15%
+21,273
New +$686K
ANAC
53
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$809K 0.15%
40,424
+7,132
+21% +$138K
RPRX
54
DELISTED
Repros Therapeutics Inc.
RPRX
$783K 0.14%
44,115
-4,492
-9% -$86.9K
CX icon
55
Cemex
CX
$16.3B
$650K 0.12%
+60,182
New +$649K
MDVN
56
DELISTED
MEDIVATION, INC.
MDVN
$644K 0.12%
20,020
-419,942
-95% -$15.5M
BRKR icon
57
Bruker
BRKR
$8.14B
$638K 0.12%
27,989
-3,233
-10% -$70.5K
OCR
58
DELISTED
OMNICARE INC
OCR
$622K 0.11%
10,429
+6,527
+167% +$396K
TXMD icon
59
TherapeuticsMD
TXMD
$24M
$598K 0.11%
+1,895
New +$603K
CI icon
60
Cigna
CI
$74.6B
$558K 0.1%
+6,659
New +$548K
RVNC
61
DELISTED
Revance Therapeutics, Inc.
RVNC
$397K 0.07%
+12,590
New +$393K
KPTI icon
62
Karyopharm Therapeutics
KPTI
$48M
$375K 0.07%
810
-1,199
-60% -$608K
FRX
63
DELISTED
FOREST LABORATORIES INC
FRX
$302K 0.06%
+3,269
New +$264K
BLUE
64
DELISTED
bluebird bio
BLUE
$260K 0.05%
884
+167
+23% +$50.6K
MGNX icon
65
MacroGenics
MGNX
$257M
$229K 0.04%
8,211
+5,527
+206% +$195K
RVTY icon
66
Revvity
RVTY
$12.8B
$206K 0.04%
+4,572
New +$201K
EIGR
67
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$181K 0.03%
+34
New +$161K
SAVE
68
DELISTED
Spirit Airlines, Inc.
SAVE
$131K 0.02%
+2,205
New +$116K
CSLT
69
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$80K 0.01%
+3,777
New +$109K
MYGN icon
70
Myriad Genetics
MYGN
$312M
$55K 0.01%
1,609
-11,204
-87% -$347K
TEVA icon
71
CALL
Teva Pharmaceuticals
TEVA
$41.2B
$22K ﹤0.01%
+15,900
New +$735K
ADBE icon
72
Adobe
ADBE
$105B
-189,066
Closed -$11.3M
AMT icon
73
American Tower
AMT
$80.4B
-151,859
Closed -$12.1M
AMZN icon
74
Amazon
AMZN
$2.96T
-1,055,660
Closed -$21M
BIDU icon
75
Baidu
BIDU
$37.2B
-34,981
Closed -$6.22M

Similar funds

Partner Investment Management's Q1 2014 Portfolio in Review

As of Q1 2014, Partner Investment Management held 98 positions worth $542M, up 23% from $441M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Partner Investment Management deployed $77.5M of net new capital in Q1 2014, opening 38 new positions and adding to 20 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 1,195,800 shares worth $49M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 35% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was MEDIVATION, INC., an estimated $15.5M trimmed.

  • Partner Investment Management's largest Q1 2014 buy was iShares MSCI Emerging Markets ETF: 1,195,800 shares worth $49M.
  • Partner Investment Management added most to Workday in Q1 2014, an estimated $10.5M increase.
  • Partner Investment Management's biggest Q1 2014 reduction was MEDIVATION, INC., cutting an estimated $15.5M.
  • Partner Investment Management fully exited Amazon in Q1 2014, selling an estimated $21M.
  • Partner Investment Management's ten largest holdings make up 48% of its $542M portfolio in Q1 2014.
  • Partner Investment Management opened 38 new positions and closed 26 in Q1 2014.
  • Partner Investment Management's portfolio value rose 23% quarter-over-quarter to $542M.

Based on Partner Investment Management's 13F filing for Q1 2014, filed 15 May 2014.